Can we vaccinate against depression?

Drug Discovery Today

Volumn 17, Issue 9-10, 2012, Pages 451-458

  Rook, Graham A W ^a   Raison, Charles L ^b   Lowry, Christopher A ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MYCOBACTERIUM VACCAE VACCINE; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

BRAIN; COGNITION; DEPRESSION; DEVELOPING COUNTRY; ENVIRONMENTAL ASPECTS AND RELATED PHENOMENA; HELMINTH; HUMAN; IMMIGRANT; IMMUNOREGULATION; INFLAMMATION; INTESTINE FLORA; MOOD; MYCOBACTERIUM VACCAE; NONHUMAN; REVIEW; T LYMPHOCYTE; VACCINATION;

ANIMALS; BRAIN; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; INFLAMMATION; INTESTINES; VACCINES;

EID: 84860686903     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.03.018     Document Type: Review

References (62)

1. L. Wen Innate immunity and intestinal microbiota in the development of type 1 diabetes Nature 455 2008 1109 1113
2. P.D. Cani, and N.M. Delzenne The gut microbiome as therapeutic target Pharmacol. Ther. 130 2011 202 212
3. C. De Filippo Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa Proc. Natl Acad. Sci. U. S. A. 107 2010 14691 14696
4. C.L. Raison Inflammation, sanitation and consternation: loss of contact with co-evolved, tolerogenic micro-organisms and the pathophysiology and treatment of major depression Arch. Gen. Psychiatry 67 2010 1211 1224
5. M.B. Howren Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis Psychosom. Med. 71 2009 171 186
6. Y. Dowlati A meta-analysis of cytokines in major depression Biol. Psychiatry 67 2010 446 457
7. D.L. Musselman Paroxetine for the prevention of depression induced by high-dose interferon alfa N. Engl. J. Med. 344 2001 961 966
8. L. Capuron Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? J. Affect. Disord. 119 2009 181 185
9. A. Buske-Kirschbaum Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris Brain Behav. Immun. 21 2007 92 99
10. E. Freier Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor Psychoneuroendocrinology 35 2010 663 673
11. R. Dantzer Identification and treatment of symptoms associated with inflammation in medically ill patients Psychoneuroendocrinology 33 2008 18 29
12. G.E. Simon Is the lifetime risk of depression actually increasing? J. Clin. Epidemiol. 48 1995 1109 1118
13. W.A. Vega 12-month prevalence of DSM-III-R psychiatric disorders among Mexican Americans: nativity, social assimilation, and age determinants J. Nerv. Ment. Dis. 192 2004 532 541
14. J. Peen The current status of urban-rural differences in psychiatric disorders Acta Psychiatr. Scand. 121 2010 84 93
15. F. Lederbogen City living and urban upbringing affect neural social stress processing in humans Nature 474 2011 498 501
16. J. Riedler Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey Lancet 358 2001 1129 1133
17. Y. Osada, and T. Kanazawa Parasitic helminths: new weapons against immunological disorders J. Biomed. Biotechnol. 2010 2010 743 758
18. J. Correale, and M. Farez Association between parasite infection and immune responses in multiple sclerosis Ann. Neurol. 61 2007 97 108
19. J. Correale, and M.F. Farez The impact of parasite infections on the course of multiple sclerosis J. Neuroimmunol. 233 2011 6 11
20. J. Fleming Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study Mult. Scler. 17 2011 743 754
21. L.M. Iyer Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role? Trends Genet. 20 2004 292 299
22. W.R. Wikoff Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites Proc. Natl Acad. Sci. U. S. A. 106 2009 3698 3703
23. P. Bercik The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice Gastroenterology 141 2011 599 609
24. W. Li Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria Physiol. Behav. 96 2009 557 567
25. N. Sudo The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction J. Immunol. 159 1997 1739 1754
26. N. Sudo Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice J. Physiol. 558 2004 263 275
27. G.A.W. Rook 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the 'hygiene' or 'old friends' hypothesis Clin. Exp. Immunol. 160 2010 70 79
28. L. Desbonnet Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression Neuroscience 170 2010 1179 1188
29. M. Messaoudi Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects Br. J. Nutr. 105 2011 755 764
30. A.V. Rao A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome Gut Pathog. 1 2009 6
31. R.W. Summers Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial Gastroenterology 128 2005 825 832
32. C. Zuany-Amorim Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells Nat. Med. 8 2002 625 629
33. N. Dalbeth A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis Ann. Rheum. Dis. 63 2004 718 722
34. M.E. O'Brien SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results Ann. Oncol. 15 2004 906 914
35. M.E. O'Brien A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma Br. J. Cancer 83 2000 853 857
36. N. Le Bert DC priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathway PLoS ONE 6 2011 E18346
37. A.Y. Wen The role of the transcription factor CREB in immune function J. Immunol. 185 2010 6413 6419
38. P. Gass, and M.A. Riva CREB, neurogenesis and depression Bioessays 29 2007 957 961
39. C.A. Lowry Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior Neuroscience 146 2007 756 772
40. C.A. Lowry That warm fuzzy feeling: brain serotonergic neurons and the regulation of emotion J. Psychopharmacol. 23 2009 392 400
41. J. Kipnis Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity J. Neuroimmunol. 130 2002 78 85
42. G.A. Rook Lymphocytes in neuroprotection, cognition and emotion: is intolerance really the answer? Brain Behav. Immun. 25 2011 591 601
43. G.M. Lewitus Reducing post-traumatic anxiety by immunization Brain Behav. Immun. 22 2008 1108 1114
44. G.M. Lewitus Vaccination as a novel approach for treating depressive behavior Biol. Psychiatry 65 2009 283 288
45. N.C. Derecki Alternatively activated myeloid (M2) cells enhance cognitive function in immune compromised mice Brain Behav. Immun. 25 2011 379 385
46. N.C. Derecki Regulation of learning and memory by meningeal immunity: a key role for IL-4 J. Exp. Med. 207 2010 1067 1080
47. J. Xin IL-10 within the CNS is necessary for CD4(+) T cells to mediate neuroprotection Brain Behav. Immun. 25 2011 820 829
48. M. Schwartz, and R. Shechter Protective autoimmunity functions by intracranial immunosurveillance to support the mind: the missing link between health and disease Mol. Psychiatry 15 2010 342 354
49. J.F. Bach The effect of infections on susceptibility to autoimmune and allergic diseases N. Engl. J. Med. 347 2002 911 920
50. R.S. Wildin Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome J. Med. Genet. 39 2002 537 545
51. T.W. McDade Early origins of inflammation: microbial exposures in infancy predict lower levels of C-reactive protein in adulthood Proc. Biol. Sci. 277 2010 1129 1137
52. D.P. Strachan Hay fever, hygiene, and household size Br. Med. J. 299 1989 1259 1260
53. N. Aichbhaumik Prenatal exposure to household pets influences fetal immunoglobulin E production Clin. Exp. Allergy 38 2008 1787 1794
54. J.L. Round The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota Science 332 2011 974 977
55. O. Kohashi Reverse effect of gram-positive bacteria vs. gram-negative bacteria on adjuvant-induced arthritis in germfree rats Microbiol. Immunol. 29 1985 487 497
56. Y. Umesaki Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system Infect. Immun. 67 1999 3504 3511
57. M.B. Geuking Intestinal bacterial colonization induces mutualistic regulatory T cell responses Immunity 34 2011 794 806
58. K. Atarashi Induction of colonic regulatory T cells by indigenous clostridium species Science 331 2011 337 341
59. S.T. Walk Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus Inflamm. Bowel Dis. 16 2010 1841 1849
60. L. Hang Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity J. Immunol. 185 2010 3184 3189
61. J.R. Grainger Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway J. Exp. Med. 207 2010 2331 2341
62. G.A.W. Rook Microbes and mood: a new approach to the therapy of depression? Microbiologist 12 2011 32 36